6,7,8-trimethoxy-2-(1H-pyrrol-2-yl)-3,4-dihydroquinazolin-4-one
Structure Info
- Chemspace ID
- CSSB06354214109 (In-Stock Building Blocks)
- CAS
- 2700216-93-7
- MFCD
- MFCD34575851
- IUPAC Name
- 6,7,8-trimethoxy-2-(1H-pyrrol-2-yl)-3,4-dihydroquinazolin-4-one
- Mol formula
- C15H15N3O4
- Mol weight
- 301 Da
- Catalog Number(s)
- ArZ-UP356842, BD01576894, BL65788, EN300-37148765, TX028R0G, Y3182592, ZXC349027
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.15
- Heavy atoms count
- 22
- Rotatable bond count
- 4
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.2
- Polar surface area (Å)
- 85
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 2
- Zoom the structure
- CSSB06354214109
Items Overall 13 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine US, Inc. | 5 days | United States To: | 95 | 50 mg | 262.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 100 mg | 392.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 250 mg | 559.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 500 mg | 879.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 1 g | 1,129.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 262.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 392.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 559.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 879.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 1,129.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 2,211.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 3,273.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 4,852.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 1-[2,3-dimethoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(thiophen-2-yl)urea - CSSB21332085101](/st/structure/200/892d646caf75faa8ae94c8115458ea97/COC1%253DC%2528OC%2529C%2528NC%2528%253DO%2529NC2%253DCC%253DCS2%2529%253DCC%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 3-(5-bromothiophen-3-yl)-1-[2,3-dimethoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea - CSSB21332092585](/st/structure/200/6c9e7361628bdb0449201d541af90c0e/COC1%253DC%2528OC%2529C%2528NC%2528%253DO%2529NC2%253DCSC%2528Br%2529%253DC2%2529%253DCC%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 3,4,5-trimethoxy-N-[2-(thiophen-2-yl)ethyl]benzamide - CSSB00046270364](/st/structure/200/2ad293627657d41ba0e2cc59f4c4ba7b/COC1%253DCC%2528%253DCC%2528OC%2529%253DC1OC%2529C%2528%253DO%2529NCCC1%253DCC%253DCS1.png)
![Chemical structure of 1-[2,3-dimethoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(3-methylthiophen-2-yl)urea - CSSB21332045455](/st/structure/200/bca743413786ead9b13099cfed855df8/COC1%253DC%2528OC%2529C%2528NC%2528%253DO%2529NC2%253DC%2528C%2529C%253DCS2%2529%253DCC%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
